50419-348 NDC - ULTRAVIST (IOPROMIDE)

Drug Information

Product NDC: 50419-348

Proprietary Name: Ultravist

Non Proprietary Name: iopromide

Active Ingredient(s):
  • 370 mg/mL IOPROMIDE


Administration Route(s): INTRA-ARTERIAL; INTRAVENOUS

Dosage Form(s): INJECTION

Pharmacy Class(es):
  • Radiographic Contrast Agent [EPC];
  • X-Ray Contrast Activity [MoA]

Labeler Information

Labeler Name: Bayer HealthCare Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Start Marketing Date:6/8/2022

Package Information

No. Package Code Package Description Billing Unit
150419-348-0510 VIAL, GLASS in 1 CARTON (50419-348-05) / 50 mL in 1 VIAL, GLASSML
250419-348-10100 mL in 1 VIAL, GLASS (50419-348-10)ML
350419-348-11100 mL in 1 VIAL, GLASS (50419-348-11)ML
450419-348-1210 VIAL, GLASS in 1 CARTON (50419-348-12) / 100 mL in 1 VIAL, GLASSML
550419-348-1310 VIAL, GLASS in 1 CARTON (50419-348-13) / 100 mL in 1 VIAL, GLASSML
650419-348-20200 mL in 1 VIAL, GLASS (50419-348-20)ML
750419-348-2110 VIAL, GLASS in 1 CARTON (50419-348-21) / 200 mL in 1 VIAL, GLASSML

NDC Record

Field Name Field Value Definition
PRODUCT NDC50419-348The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEUltravistThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEiopromideThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEINJECTIONThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEINTRA-ARTERIAL; INTRAVENOUSThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/8/2022This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG FOR USE IN DRUG SHORTAGEProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBayer HealthCare Pharmaceuticals Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEIOPROMIDEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH370 
ACTIVE INGRED UNITmg/mL 
PHARM CLASSESRadiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023